Shukla Sanjay — SEC Form 4 filings
SEC reporting owner CIK 1671026. 7 Form 4 filings on record with FilingPulse; latest filed 2026-02-04.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-01-09 to 2026-02-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 20,000 shares, $36,140 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 3,745 shares, $3,655 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: purchase of 20,000 shares @ $1.81 ($36,140) in aTYR PHARMA INC, filed 2024-06-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| aTYR PHARMA INC (ATYR) | President and CEO, Director | 7 | 1 leg · 20,000 sh · $36,140 | 1 leg · 3,745 sh · $3,655 | 9 |
Form 4 filings — Shukla Sanjay
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-04 | 4 | aTYR PHARMA INC (ATYR) | Option exercise (M): 10,375 · Sale (S): 3,745 @ $0.98 · Option exercise (M): 10,375 (derivative) @ $0 | EDGAR |
| 2026-01-09 | 4 | aTYR PHARMA INC (ATYR) | Grant/award (A): 1,500,000 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | aTYR PHARMA INC (ATYR) | Option exercise (M): 10,375 · Option exercise (M): 10,375 (derivative) @ $0 | EDGAR |
| 2025-01-10 | 4 | aTYR PHARMA INC (ATYR) | Grant/award (A): 1,000,000 (derivative) @ $0 | EDGAR |
| 2024-06-03 | 4 | aTYR PHARMA INC (LIFE) | Purchase (P): 20,000 @ $1.81 | EDGAR |
| 2024-02-06 | 4 | aTYR PHARMA INC (LIFE) | Option exercise (M): 10,375 · Option exercise (M): 10,375 (derivative) @ $0 | EDGAR |
| 2024-01-09 | 4 | aTYR PHARMA INC (LIFE) | Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1671026 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →